تجاوز إلى المحتوى الرئيسي
drug protocol number
RPC01-3203
drug sponsor
Celgene
drug study
Ozanimod HCl
drug trial site
King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh)
drug status
Ongoing
drug phase